| Financial Year |
March 31 2023 |
| Monetary Funds |
1,425,685,714.17 |
| Held-for-trading Financial Assets |
894,797,722.22 |
| Notes Receivable |
213,995,972.21 |
| Accounts Receivable |
960,342,880.10 |
| Advances to Suppliers |
304,880,254.09 |
| Other Receivables |
31,772,083.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
948,457,077.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
142,191,587.79 |
| Total Current Assets |
5,940,962,596.98 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
49,605,361.19 |
| Investment Properties |
4,658,486.01 |
| Fixed Assetes |
1,065,866,925.08 |
| Under-construction Projects |
415,506,137.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
312,744,263.03 |
| R&D expenses |
-- |
| Goodwill |
87,320,433.78 |
| Long-Term Deferred and Prepaid Expenses |
79,685,725.94 |
| Deferred Income Tax Assets |
41,137,298.33 |
| Other Non-Current Assets |
32,170,173.76 |
| Sub-Total of Non-Current Assets |
2,289,559,412.58 |
| Total Assets |
8,230,522,009.56 |
| Short-Term Loans |
373,417,092.62 |
| Trading Financial liabilities |
-- |
| Notes Payable |
660,458,191.29 |
| Accounts Payable |
857,370,926.25 |
| Accounts Received In Advance |
123,750.00 |
| Employee Compensation Payable |
45,825,234.08 |
| Taxes Payable |
25,725,730.61 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
117,442,768.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
227,697,255.75 |
| Other Current Liabilities |
440,898,469.69 |
| Sub-Total of Current Liabilities |
2,906,152,663.88 |
| Long-term Loans |
628,534,438.75 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
25,278,662.85 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
862,620,452.27 |
| Total Liabilities |
3,768,773,116.15 |
| Paid-In Capital(Or Share Stock) |
1,174,016,745.00 |
| Capital Surplus |
4,086,482,107.82 |
| Surplus Reserve |
148,038,522.27 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-957,373,905.29 |
| Minority Stockholder's Interest |
24,945,671.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,436,803,222.05 |
| Owner's Equity（Stockholder's Equity） |
4,461,748,893.41 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,230,522,009.56 |
